Lumen Bio discovers, develops, & manufactures biologic drugs and vaccine candidates for several prevalent, worldwide diseases.
Lumen Bio is a clinical-stage biotechnology company developing topically and mucosally delivered biologic drugs to treat and prevent highly prevalent diseases.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Sep 24, 2020 | Grant | $4M | 1 | U.S. Army Medical Research & Development Command | — | Detail |
Sep 1, 2020 | Series B | $16M | 1 | — | — | Detail |
Dec 5, 2017 | Grant | $1.80M | 1 | US Department of Energy | — | Detail |
Dec 5, 2017 | Series A | $11.20M | 1 | Avista Development | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
U.S. Army Medical Research & Development Command | Yes | Grant |
US Department of Energy | Yes | Grant |
Avista Development | — | Series B |